Reporte zur Charge EN6204 301308A

Symptomtext

tested positive for COVID-19 the first time on 16Apr2022; tested positive for COVID-19 the first time on 16Apr2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Feb2021 at 12:00 as dose 1, single (Batch/Lot number: unknown), in right arm, on 11Mar2021 at 12:00 as dose 2, single (Lot number: EN6201), in right arm and on 06Oct2021 at 12:00 as dose 3 (booster), single (Lot number: EN6204 301308A) at the age of 62 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: LEXAPRO. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 16Apr2022, outcome "unknown" and all described as "tested positive for COVID-19 the first time on 16Apr2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16Apr2022) Positive; (unspecified date) Unknown results, notes: no results back yet; (26Apr2022) Negative, notes: Took a rapid test and tested negative to it 10 days later"; (11May2022) Positive, notes: I wanted to go out yesterday; (12May2022) Positive, notes: I tested again today this morning. Therapeutic measures were taken as a result of covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.